Advertisement

Topics

Genmab Inc. Company Profile

14:46 EST 18th November 2017 | BioPortfolio

Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions, and intends to continue assembling a broad portfolio of new therapeutic products. At present, Genmab has multiple partnerships to gain access to disease targets and develop novel human antibodies including agreements with Roche and Amgen. A broad alliance provides Genmab with access to Medarex, Inc.’s array of proprietary technologies, including the UltiMAb® platform for the rapid creation and development of human antibodies to virtually any disease target. Genmab is an international company with operations in Europe and the United States.

Location

457 North Harrison Street
Princeton
New Jersey
08540
United States of America

Contact

Phone: 1 609 430-2481
Fax: 1 609 430-2482
Email: info@genmab.com


News Articles [71 Associated News Articles listed on BioPortfolio]

Genmab A/S: Articles of Association for Genmab A/S

Genmab A/S has published its Articles of Association dated November 14, 2017. The Articles of Association can be found on Genmab's website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis ...

Welcome to the Blockbuster Club, Genmab!

Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a great example for other European biotechs to follow. Genmab has officially joined the elite of the biotech world ...

Genmab A/S: Genmab Announces Data to be Presented at 2017 ASH Annual Meeting

Media Release -- Over 25 abstracts on Genmab partnered programs scheduled for presentation at ASH -- Daratumumab: 6 oral presentations; Total of over 20 abstracts accepted including ISSCopenhagen, ...

Genmab A/S: Genmab to Present at Morgan Stanley 15th Annual Global Healthcare Conference

Media ReleaseCopenhagen, Denmark; September 5, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will give a company update at the Morgan Stanley 15...

Genmab A/S: Genmab to Present at the Jefferies 2017 London Healthcare Conference

Media ReleaseCopenhagen, Denmark; November 7, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company's CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies 20...

Genmab A/S: Genmab's Financial Calendar for 2018

Company AnnouncementCopenhagen, Denmark; November 3, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announces its financial calendar for 2018 as follows: EVENT DATE ------------------------------------...

Genmab A/S: Major Shareholder Announcement

Company Announcement -- Major shareholder announcement for Genmab A/SCopenhagen, Denmark; November 9, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danis...

Genmab A/S: Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company AnnouncementCopenhagen, Denmark; November 14, 2017 - Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 22,532 shares as a consequence of the exercise of employee warran...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Genmab Inc.

Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat c...

Genmab A/S

Genmab is a leading international biotechnology company that aims to improve the lives of patients by creating and developing innovative antibody products. The company was founded in Copenhagen, Den...

TenX Biopharma, Inc.

TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...

More Information about "Genmab Inc." on BioPortfolio

We have published hundreds of Genmab Inc. news stories on BioPortfolio along with dozens of Genmab Inc. Clinical Trials and PubMed Articles about Genmab Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genmab Inc. Companies in our database. You can also find out about relevant Genmab Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record